Horizon Therapeutics PLC (HZNP)

Add to Watchlists
Create an Alert
Quickflows
91.27 -1.29  -1.39% NASDAQ Jun 15, 12:01 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All HZNP News

News

View All Events

Events

Date Type Description
08/05/2021 Earnings Results Q2 2021 Earnings Results
08/05/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
05/05/2021 Earnings Results Q1 2021 Earnings Results
05/05/2021 08:00 EST Earnings Calls Q1 2021 Earnings Call
04/29/2021 15:00 EST AGM 2020 Annual General Meeting
02/24/2021 Earnings Results Q4 2020 Earnings Results
02/24/2021 08:00 EST Earnings Calls Q4 2020 Earnings Call
11/02/2020 Earnings Results Q3 2020 Earnings Results
11/02/2020 08:00 EST Earnings Calls Q3 2020 Earnings Call
08/05/2020 08:00 EST Earnings Calls Q2 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 2.187B
Total Expenses (TTM) 1.833B
Net Income (TTM) 280.04M

Balance Sheet View Statement

Total Assets (Quarterly) 7.847B
Total Liabilities (Quarterly) 3.992B
Shareholders Equity (Quarterly) 3.855B

Cash Flow Statement View Statement

Cash from Operations (TTM) 614.55M
Cash from Investing (TTM) -2.975B
Cash from Financing (TTM) 2.413B

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division. The majority of revenue is generated in the United States.
  • URL: https://www.horizontherapeutics.com
  • Investor Relations URL: https://ir.horizontherapeutics.com
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Aug. 05, 2021
  • Last Earnings Release: May. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 91.27
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
JCNIX Janus Henderson Contrarian S 4.85%
IHE iShares US Pharmaceuticals ETF 4.40%
PTH Invesco DWA Healthcare Momentum ETF 4.13%
PJP Invesco Dynamic Pharmaceuticals ETF 3.05%
DBMCX BNY Mellon Sm/Md Cp Gr C 1.98%
IBB iShares Nasdaq Biotechnology ETF 1.64%
HQH Tekla Healthcare Investors 1.59%
HRAYX Carillon Eagle Mid Cap Growth Y 1.56%
IEOTX Voya Large Cap Growth Port S2 1.39%
JMGQX JPMorgan Mid Cap Growth R4 1.31%
PDP Invesco DWA Momentum ETF 1.25%
JGMCX Janus Henderson Triton C 1.18%

Comparables

Edit
JAZZ Jazz Pharmaceuticals PLC
PRGO Perrigo Co PLC
ALKS Alkermes PLC
ITRM Iterum Therapeutics PLC
ENDP Endo International PLC

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.